Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma
Authors:
- 3 August 2013
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 62 (10) , 1575-1585
Abstract
The proinflammatory cytokine interleukin 17 (IL-17) is considered to play a crucial role in diverse human tumors; however, its role in disease progression remains controversial. This study investigated the cellular source and distribution of IL-17 in esophageal squamous cell carcinoma (ESCC) in situ and determined its prognostic value. Immunohistochemistry, immunofluorescence and immunoelectron microscopy were used to identify IL-17-expressing cells in ESCC tissues, paying particular attention to their anatomic localization. Kaplan–Meier analysis and Cox proportional hazards regression models were applied to estimate overall survival in 215 ESCC patients with long-term follow-up (>10 years). The results showed that mast cells, but not T cells or macrophages, were the predominant cell type expressing IL-17 in ESCC tissues. Unexpectedly, these IL-17+ cells were highly enriched in the muscularis propria rather than the corresponding tumor nest (p < 0.0001). The density of IL-17+ cells in muscularis propria was inversely associated with tumor invasion (p = 0.016) and served as an independent predictor of favorable survival (p = 0.007). Moreover, the levels of IL-17+ cells in muscularis propria were positively associated with the density of effector CD8+ T cells and activated macrophages in the same area (both p < 0.0001). This finding suggested that mast cells may play a significant role in tumor immunity by releasing IL-17 at a previously unappreciated location, the muscularis propria, in ESCC tissues, which could serve as a potential prognostic marker and a novel therapeutic target for ESCC.Keywords
This publication has 44 references indexed in Scilit:
- Regulation of TH17 cell differentiation by innate immune signalsCellular & Molecular Immunology, 2012
- Blocking Lymphocyte Localization to the Gastrointestinal Mucosa as a Therapeutic Strategy for Inflammatory Bowel DiseasesGastroenterology, 2011
- CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated AntigensImmunity, 2011
- Mast cell-orchestrated immunity to pathogensNature Reviews Immunology, 2010
- TH17 cells in tumour immunity and immunotherapyNature Reviews Immunology, 2010
- Immunity, Inflammation, and CancerCell, 2010
- New developments in mast cell biologyNature Immunology, 2008
- Cancer-related inflammationNature, 2008
- Immunomodulatory mast cells: negative, as well as positive, regulators of immunityNature Reviews Immunology, 2008
- Development, cytokine profile and function of human interleukin 17–producing helper T cellsNature Immunology, 2007